In the present study, by incorporating a depressed group of women as additional controls to the SSRI users we are able to show additive effects by depression and SSRI use on certain aspects of NGF signaling (ROCK2 and phosphorylated ROCK2). This evidence concerns the gene NGF and depressive disorder.